Creative Biolabs-Immuno-oncology

Anti-DR5 (clone AMG6Z5L5L) SynExpress C-mCh-I4-K Modified CD8+ T cells (CAT#: ITS-1224-CR2268)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DR5 (clone AMG6Z5L5L). We employs the pGEX (CMV-mCherry-IL-4-KpnI) vector components and the SynExpress system of the Exons Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
DR5
Clone
AMG6Z5L5L
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mCherry
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
pGEX
Transformation Accuracy
0.9
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving